340 related articles for article (PubMed ID: 35223512)
21. Serine protease inhibitor Kazal-type 2 is expressed in the male reproductive tract of carp with a possible role in antimicrobial protection.
Dietrich MA; Słowińska M; Karol H; Adamek M; Steinhagen D; Hejmej A; Bilińska B; Ciereszko A
Fish Shellfish Immunol; 2017 Jan; 60():150-163. PubMed ID: 27867114
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic targeting of SPINK1-positive prostate cancer.
Ateeq B; Tomlins SA; Laxman B; Asangani IA; Cao Q; Cao X; Li Y; Wang X; Feng FY; Pienta KJ; Varambally S; Chinnaiyan AM
Sci Transl Med; 2011 Mar; 3(72):72ra17. PubMed ID: 21368222
[TBL] [Abstract][Full Text] [Related]
23. The mode of reproductive-derived Spink (serine protease inhibitor Kazal-type) action in the modulation of mammalian sperm activity.
Ou CM; Tang JB; Huang MS; Sudhakar Gandhi PS; Geetha S; Li SH; Chen YH
Int J Androl; 2012 Feb; 35(1):52-62. PubMed ID: 21831237
[TBL] [Abstract][Full Text] [Related]
24. Genetic background of pancreatitis.
Hirota M; Ohmuraya M; Baba H
Postgrad Med J; 2006 Dec; 82(974):775-8. PubMed ID: 17148697
[TBL] [Abstract][Full Text] [Related]
25. SPINK1 is a prognosis predicting factor of non-small cell lung cancer and regulates redox homeostasis.
Guo M; Zhou X; Han X; Zhang Y; Jiang L
Oncol Lett; 2019 Dec; 18(6):6899-6908. PubMed ID: 31788129
[TBL] [Abstract][Full Text] [Related]
26. SPINK1 mutations are associated with multiple phenotypes.
Pfützer RH; Whitcomb DC
Pancreatology; 2001; 1(5):457-60. PubMed ID: 12120224
[TBL] [Abstract][Full Text] [Related]
27. Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma.
Shek FH; Luo R; Lam BYH; Sung WK; Lam TW; Luk JM; Leung MS; Chan KT; Wang HK; Chan CM; Poon RT; Lee NP
Cell Oncol (Dordr); 2017 Oct; 40(5):443-456. PubMed ID: 28631187
[TBL] [Abstract][Full Text] [Related]
28. TATI as a biomarker.
Itkonen O; Stenman UH
Clin Chim Acta; 2014 Apr; 431():260-9. PubMed ID: 24583226
[TBL] [Abstract][Full Text] [Related]
29. Serine peptidase inhibitor Kazal type I (SPINK1) promotes BRL-3A cell proliferation via p38, ERK, and JNK pathways.
Chang C; Zhao W; Luo Y; Xi L; Chen S; Zhao C; Wang G; Guo J; Xu C
Cell Biochem Funct; 2017 Aug; 35(6):339-348. PubMed ID: 28845526
[TBL] [Abstract][Full Text] [Related]
30. Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue.
Lu Z; Williamson SR; Carskadon S; Arachchige PD; Dhamdhere G; Schultz DS; Stricker H; Peabody JO; Jeong W; Chitale DA; Bismar TA; Rogers CG; Menon M; Gupta NS; Palanisamy N
Prostate; 2020 Jan; 80(1):38-50. PubMed ID: 31584209
[TBL] [Abstract][Full Text] [Related]
31. Hereditary pancreatitis as the premalignant disease: a Japanese case of pancreatic cancer involving the SPINK1 gene mutation N34S.
Masamune A; Mizutamari H; Kume K; Asakura T; Satoh K; Shimosegawa T
Pancreas; 2004 Apr; 28(3):305-10. PubMed ID: 15084977
[TBL] [Abstract][Full Text] [Related]
32. SPINK1/PSTI mutations are associated with tropical pancreatitis in Bangladesh. A preliminary report.
Rossi L; Pfützer RH; Parvin S; Ali L; Sattar S; Kahn AK; Gyr N; Whitcomb DC
Pancreatology; 2001; 1(3):242-5. PubMed ID: 12120202
[TBL] [Abstract][Full Text] [Related]
33. The prevalence of cationic trypsinogen (PRSS1) and serine protease inhibitor, Kazal type 1 (SPINK1) gene mutations in Polish patients with alcoholic and idiopathic chronic pancreatitis.
Gasiorowska A; Talar-Wojnarowska R; Czupryniak L; Smolarz B; Romanowicz-Makowska H; Kulig A; Malecka-Panas E
Dig Dis Sci; 2011 Mar; 56(3):894-901. PubMed ID: 20676769
[TBL] [Abstract][Full Text] [Related]
34. The construction and proliferative effects of a lentiviral vector capable of stably overexpressing SPINK1 gene in human pancreatic cancer AsPC-1 cell line.
Zhang J; Wang D; Hu N; Wang Q; Yu S; Wang J
Tumour Biol; 2016 May; 37(5):5847-55. PubMed ID: 26586397
[TBL] [Abstract][Full Text] [Related]
35. MAPK inhibitors induce serine peptidase inhibitor Kazal type 1 (SPINK1) secretion in BRAF V600E-mutant colorectal adenocarcinoma.
Räsänen K; Dang KX; Mustonen H; Ho TH; Lintula S; Koistinen H; Stenman UH; Haglund C; Stenman J
Mol Oncol; 2018 Feb; 12(2):224-238. PubMed ID: 29193645
[TBL] [Abstract][Full Text] [Related]
36. Role of Intrapancreatic SPINK1/Spink3 Expression in the Development of Pancreatitis.
Ohmuraya M; Sugano A; Hirota M; Takaoka Y; Yamamura K
Front Physiol; 2012; 3():126. PubMed ID: 22586407
[TBL] [Abstract][Full Text] [Related]
37. Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer.
Soon WW; Miller LD; Black MA; Dalmasso C; Chan XB; Pang B; Ong CW; Salto-Tellez M; Desai KV; Liu ET
EMBO Mol Med; 2011 Aug; 3(8):451-64. PubMed ID: 21656687
[TBL] [Abstract][Full Text] [Related]
38. Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis.
Drenth JP; te Morsche R; Jansen JB
Gut; 2002 May; 50(5):687-92. PubMed ID: 11950817
[TBL] [Abstract][Full Text] [Related]
39. TNF-α and IL-17A induce the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
Sugihara S; Sugimoto S; Tachibana K; Kobashi M; Nomura H; Miyake T; Hirai Y; Yamasaki O; Morizane S
J Dermatol Sci; 2019 Oct; 96(1):26-32. PubMed ID: 31501002
[TBL] [Abstract][Full Text] [Related]
40. SPINK1, ADH2, and ALDH2 gene variants and alcoholic chronic pancreatitis in Japan.
Shimosegawa T; Kume K; Masamune A
J Gastroenterol Hepatol; 2008 Mar; 23 Suppl 1():S82-6. PubMed ID: 18336671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
